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Background:  Most  studies  pay  attention  to  the  relationship  between  insulin  resistance  and coronary  artery
disease  (CAD)  in patients  with  abnormal  glucose  tolerance.  But  few  studies  have  focused  on  the role  of
insulin  secretion.  The  aim  of  this  study  was  to investigate  the  association  between  insulin  sensitivity,
insulin  secretion,  and  CAD  in patients  with  different  glucose  metabolic  status.
Methods: 316  newly  diagnosed  patients  with  different  glucose  metabolic  status  (according  to  the  results
of oral glucose  tolerance  test)  were  included  in  this  study.  The  homeostasis  model  assessment  of insulin
resistance  (HOMAIR)  and  Matsuda  index  were  used  to  estimate  insulin  sensitivity;  the  insulin  secretion
was  assessed  using  the  HOMA-,  insulinogenic  index,  area  under  the  curve  – insulin/glucose  (AUC-
Ins/Glu).  CAD  was  deﬁned  as  ≥50%  of  luminal  stenosis  in  at  least  one  major  coronary  vessel  through
coronary  angiography.
Results: Univariate  analysis  revealed  that  HOMAIR and Matsuda  index  were  signiﬁcantly  different  between
the  CAD  group  and  the  non-CAD  group  in  all patients.  Logistic  analysis  revealed  that Matsuda  index  was  an
independent  risk  factor for  the  presence  of  CAD  in all patients,  and  HOMAIR was  an  independent  risk  factor
for  the presence  of CAD  in  normal  glucose  tolerance  patients.  Moreover,  in the  CAD  group  compared  to  the
non-CAD group,  there  was  no  signiﬁcant  difference  in the  HOMA-,  insulinogenic  index,  and  AUC-Ins/Glu
in  all  patients.
Conclusions:  Insulin  resistance  is  closely  related  to the presence  of  CAD  in  newly  diagnosed  patients  with
different  glucose  metabolic  status.  The  insulin  secretion  may  not  be closely  related  to the presence  of
2  Jap
CAD.
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In the Euro Heart Survey Study [1],  a total of 4196 patients with
oronary heart disease combined with glucose metabolism disor-
ers (including impaired glucose regulation and diabetes mellitus)
onstituted almost 67% of the subjects in the study. However, it is
ore serious in China. The total prevalence of abnormal glucose
etabolism was 76.9% in in-patients with coronary artery disease
CAD) according to the results of the China Heart Survey [2].  It is
ell-known that diabetes mellitus (DM) is one of the classic riskactors for CAD. It is also well known that insulin resistance and (or)
yperinsulinemia is one of the major candidates that contribute
o the development of atherosclerosis in patients with different
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niversity School of Medicine, 150 Jimo Road, Pudong District, Shanghai, Postal
ode: 200120, China. Tel.: +86 21 38804518x3094; fax: +86 21 58793427.
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ttp://dx.doi.org/10.1016/j.jjcc.2012.06.008anese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.
glucose tolerance [3,4]. Then does the insulin secretion play an
important role in coronary atherosclerosis as well as insulin resis-
tance? But few studies have focused on the role of insulin secretion
during the development of atherosclerosis with different glucose
tolerance [5–7]. Fujiwara et al. [5] reported that the elevation of
plasma insulin concentrations in both the sum and the early phase
to an oral glucose load were signiﬁcantly higher in the CAD group
than in the normal group with different glucose tolerance. There-
fore our study chose several indices of insulin sensitivity and insulin
secretion from oral glucose tolerance test (OGTT) to investigate the
relationship between CAD and insulin sensitivity as well as insulin
secretion in patients with different glucose tolerance.
Materials and methodsSubjects
A total of 493 Chinese patients with known or suspected CAD
were submitted to coronary angiography at Shanghai East Hospital
vier Ltd. All rights reserved.
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etween February 2009 and October 2009. “Suspected CAD”
eans that a patient’s symptoms or other clinical characteristics
uggest a high likelihood for signiﬁcant CAD and its related adverse
utcomes but that clinical evidence has not yet been documented
s deﬁned CAD [8].  A total of 39 patients were excluded because
f severe congestive heart failure (New York Heart Association
lass III–IV), liver dysfunction (aspartate aminotransferase and/or
lanine aminotransferase > 1.5 × upper limit of normal), and renal
ysfunction (creatinine clearance < 60 ml/min, creatinine clear-
nce was estimated from serum creatinine concentration using
he Cockcroft–Gault formula). Except for 138 patients having a
istory of type 2 DM, the remaining 316 patients were enrolled
nd underwent 75 g OGTT. According to the results of OGTT (1999
HO  criteria), the patients were divided into three groups: normal
lucose tolerance (NGT), impaired glucose regulation (IGR, includ-
ng impaired glucose tolerance and impaired fasting glucose), type
 DM. No patient enrolled in this study was diagnosed with type 1
M. The study protocol was approved by the ethics review board
f Tongji University. Written informed consent was  obtained from
ll participants, and all the procedures were done in accordance
ith the Declaration of Helsinki and relevant policies in China.
iochemical methods
All patients were evaluated considering classic risk fac-
ors for CAD throughout a medical-oriented questionnaire,
hysical examination, and laboratory assessment. Clinical data
ncluded: age, gender, body mass index (BMI), waist circum-
erence, hypertension [systolic blood pressure (SBP)/diastolic
lood pressure (DBP) ≥ 140/90 mmHg  or history of hyperten-
ion], dyslipidemia [total cholesterol (TC) ≥ 5.17 mmol/l; triglyc-
rides (TG) ≥ 1.70 mmol/l; low density lipoprotein cholesterol
LDL-C) ≥ 3.10 mmol/l; high density lipoprotein cholesterol (HDL-
) < 1.03 mmol/l or history of dyslipidemia], and smoker (“yes”
r “no”, yes smoker deﬁned as having smoked more than three
igarettes a day for at least one year), etc. Blood samples were col-
ected at 0 min, 30 min, 60 min, 120 min, and 180 min  for plasma
lucose (Glu0, Glu30, Glu60, Glu120, Glu180), insulin (Ins0, Ins30,
ns60, Ins120, Ins180), and C-peptide measurements (C-pep0,
-pep30, C-pep60, C-pep120, C-pep180) in OGTT. Insulin and C-
eptide measurements were analyzed by radio-immuno-assay
RIA). Glycosylated hemoglobin (HbA1c) was analyzed by high per-
ormance liquid chromatography (HPLC).
oronary angiography
Coronary angiography was performed via the radial or femoral
rtery. All the angiographies were interpreted by the consensus
f two independent observers blinded to the results of analysis.
he extent of lumen narrowing was measured and recorded as a
ercentage loss of lumen diameter in the narrowing area of the epi-
ardial coronary artery compared to the proximal normal coronary
rtery. CAD was deﬁned as ≥50% of luminal stenosis in at least one
ajor coronary vessel. Based on clinical manifestations, laboratory
ests, and coronary angiography, 61 patients were diagnosed with
cute myocardial infarction, 48 patients were diagnosed with sta-
le angina, 102 patients were diagnosed with unstable angina, and
05 patients were diagnosed with no CAD [those with mild stenosis
<50%) in their coronary arteries were considered to be non-CAD].nsulin sensitivity indices
The following two OGTT-based indices of insulin sensi-
ivity were studied: (1) homeostasis model assessment ofology 60 (2012) 367–371
insulin resistance (HOMAIR) = Ins0 × Glu0/22.5; (2) Matsuda index
[9] = 10,000/(Glu0 × Ins0 × mean glucose × mean insulin)0.5.
Insulin secretion indices
The following three OGTT-based measures of insulin secre-
tion were studied: (1) HOMA-; (2) insulinogenic index; (3)
ratio of the total area-under-the-insulin-curve to the total area-
under-the-glucose-curve (AUC-Ins/Glu). Insulin secretion index
was calculated as follows: HOMA- = 20 × Ins0/(Glu0 − 3.5);
insulinogenic index = (Ins30 − Ins0)/(Glu30 − Glu0); AUC-
Ins/Glu was  calculated using the trapezoidal rule applied to
the insulin and glucose curves, AUC-Ins/Glu = AUC-Ins/AUC-
Glu = (0.5 × Ins0 + Ins30 + Ins60 + Ins120 + 0.5 × Ins180)/(0.5 × Glu0
+ Glu30 + Glu60 + Glu120 + 0.5 × Glu180) [9,10].
Statistical analysis
Data are presented as mean ± SD, median
(minimum–maximum), or as percentages, as appropriate. Quanti-
tative data are presented as mean ± standard deviation or median
(minimum–maximum), and compared by t-test or one-way
ANOVA or Mann–Whitney U test between groups, whichever
was appropriate. Categorical data were expressed as rate and
compared by Chi-square test. Spearman’s correlation analysis
was conducted for the variables with the trend of correlation.
The forward conditional method was used in multivariate logistic
regression models. Statistical analyses were performed using the
SPSS package (SPSS for Windows, version 13.0; IBM, Armonk, NY,
USA). A p-value < 0.05 was considered statistically signiﬁcant.
Results
Compared with the non-CAD group in NGT patients, the CAD
group showed statistically signiﬁcant differences in hyperten-
sion (p = 0.018), waist circumference (p = 0.001), SBP (p = 0.026),
fasting insulin (p = 0.005), HOMAIR (p = 0.002), Matsuda index
(p = 0.004), LDL-C (p = 0.002), and hs-CRP (p = 0.032). Compared
with the non-CAD group in newly diagnosed IGR patients, the CAD
group showed statistically signiﬁcant differences in hypertension
(p = 0.019), smokers (p = 0.031), BMI  (p = 0.040), waist circumfer-
ence (p = 0.016), SBP (p = 0.015), fasting insulin (p = 0.041), HOMAIR
(p = 0.034), Matsuda index (p = 0.006), and hs-CRP (p = 0.007). Com-
pared with the non-CAD group in newly diagnosed DM  patients, the
CAD group showed statistically signiﬁcant differences in hyperten-
sion (p = 0.036), smokers (p = 0.011), HOMAIR (p = 0.048), Matsuda
index (p = 0.007), TG (p = 0.003), LDL-C (p = 0.001), and hs-CRP
(p = 0.028) (Table 1).
When the levels of plasma glucose, insulin, and C-peptide were
compared according to OGTT in newly diagnosed NGT, IGR, and
DM groups, there were signiﬁcant or no signiﬁcant differences in
the results between the CAD and non-CAD groups for AUC-Glu
(p = 0.007), AUC-Ins (p = 0.121), and AUC-Cp (AUC-Cp =0.5 × C-
pep0 + C-pep30 + C-pep60 + C-pep120 + 0.5 × C-pep180, p = 0.223)
in NGT patients. There were no signiﬁcant differences between
the CAD and non-CAD groups for AUC-Glu (p = 0.163), AUC-Ins
(p = 0.061), and AUC-Cp (p = 0.452) in newly diagnosed IGR patients.
Comparing results between the CAD and non-CAD groups, there
were no signiﬁcant differences for AUC-Glu (p = 0.438), AUC-Ins
(p = 0.073), and AUC-Cp (p = 0.054) in newly diagnosed DM patients
(Fig. 1).
After adjustment for gender, age, BMI, DBP, fasting glucose,
HbA1c, TC, TG, and HDL-C, multivariate logistic regression anal-
ysis showed that smoking (OR 2.537 95%CI 1.056–6.093), waist
circumference (OR 1.053 95%CI 1.010–1.098), SBP (OR 1.033 95%CI
1.008–1.058), HOMAIR (OR 2.221 95%CI 1.166–4.231), and LDL-C
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Table  1
The clinical characteristics of the divided groups.
NGT Newly diagnosed IGR Newly diagnosed DM
Non-CAD CAD Non-CAD CAD Non-CAD CAD
n (male/female) 26/28 53/31 14/11 36/15 15/11 49/27
Age  (years) 63.3 ± 7.8 65.6 ± 9.5 60.7 ± 11.4 65.4 ± 10.9 60.8 ± 10.7 64.8 ± 10.2
Hypertension (%) 53.7 73.8* 48 76.5† 61.5 80.3‡
Dyslipidemia (%) 40.7 54.8 40 45.1 53.8 57.9
Smoker (%) 27.8 35.7 28 54.9† 19.2 48.7‡
BMI  (kg/m2) 23.9 ± 2.8 25.0 ± 3.3 24.1 ± 3.8 25.8 ± 3.4† 25.1 ± 2.0 25.2 ± 2.4
Waist (cm) 82.6 ± 9.4 88.3 ± 10.4** 82.7 ± 9.2 88.5 ± 9.9† 87.0 ± 12.4 89.0 ± 15.2
SBP  (mmHg) 127.8 ± 16.7 136.8 ± 19.5* 129.7 ± 11.4 138.5 ± 15.7† 133.4 ± 14.8 144.4 ± 23.1
DBP  (mmHg) 74.4 ± 10.5 78.2 ± 11.2 77.6 ± 8.0 79.0 ± 11.0 77.6 ± 11.0 78.5 ± 12.3
Glu0  (mmol/l) 4.86 ± 0.41 4.99 ± 0.43 4.84 ± 0.34 4.97 ± 0.53 5.77 ± 0.96 6.08 ± 1.48
Ins0  (U/ml) 5.54 ± 3.05 7.04 ± 3.52* 6.16 ± 3.62 8.02 ± 3.71† 10.69 ± 6.31 12.92 ± 7.70
C-peptide0 (ng/ml) 2.69 ± 1.78 2.75 ± 1.59 2.12 ± 0.66 2.33 ± 0.58 3.30 ± 2.62 3.62 ± 2.23
HOMAIR 1.19 ± 0.64 1.56 ± 0.80** 1.34 ± 0.80 1.79 ± 0.87† 2.69 ± 1.41 3.45 ± 2.20‡
Matsuda index 9.13 ± 4.71 6.78 ± 3.14** 5.87 ± 3.92 4.03 ± 2.58†† 4.27 ± 1.25 3.49 ± 1.72‡‡
HOMA- 91.8 ± 64.8 102.3 ± 61.4 91.6 ± 50.8 113.8 ± 56.4 113.8 ± 94.5 118.8 ± 69.3
Insulinogenic index 15.8 ± 10.9 13.7 ± 9.6 10.5 ± 6.5 13.6 ± 8.5 8.79 ± 6.00 12.09 ± 8.62
AUC-Ins/Glu 6.61 ± 3.84 6.69 ± 3.26 6.22 ± 2.75 7.42 ± 3.29 6.22 ± 4.26 8.15 ± 5.35
HbA1c (%) 5.53 ± 0.39 5.60 ± 0.40 5.77 ± 0.38 5.80 ± 0.38 6.40 ± 0.95 6.42 ± 1.19
TC  (mmol/l) 4.26 ± 0.92 4.49 ± 1.18 4.51 ± 1.02 4.73 ± 2.02 4.68 ± 0.61 4.93 ± 1.24
TG  (mmol/l) 1.56 ± 0.60 1.94 ± 1.16 1.68 ± 0.67 2.01 ± 1.13 1.77 ± 0.71 2.68 ± 1.83‡‡
HDL-C (mmol/l) 1.14 ± 0.31 1.09 ± 0.35 1.10 ± 0.38 1.03 ± 0.36 1.11 ± 0.39 1.07 ± 0.30
LDL-C  (mmol/l) 2.32 ± 0.74 2.76 ± 0.83** 2.57 ± 0.79 2.53 ± 0.78 2.31 ± 0.82 2.94 ± 0.76‡‡
Scr (mol/l) 69.0 ± 12.8 71.5 ± 13.2 71.6 ± 15.5 71.7 ± 18.5 72.1 ± 13.2 73.7 ± 12.5
BUN  (mmol/l) 5.72 ± 1.18 5.76 ± 1.52 5.85 ± 1.28 5.72 ± 1.53 5.82 ± 1.36 5.93 ± 1.46
hs-CRP(mg/l) 2.21 ± 4.03 3.98 ± 4.44* 2.36 ± 2.28 4.37 ± 3.30†† 3.37 ± 2.75 5.23 ± 4.16‡
Medications, n (%)
Aspirin, n (%) 20 (37.0) 23 (27.4) 10 (40) 16 (31.4) 14 (53.8) 21 (27.6)‡
Statins, n (%) 23 (42.6) 28 (33.3) 6 (24) 9 (17.6) 10 (38.5) 20 (26.3)
ACEI/ARB, n (%) 11 (20.4) 24 (28.6) 6 (24) 24 (47.1) 5 (19.2) 17 (22.4)
Beta-blocker, n (%) 8 (14.8) 11 (13.1) 2 (8) 11 (21.6) 3 (11.5) 15 (19.7)
Ca-antagonists, n (%) 7 (13.0) 21 (25) 5 (20) 21 (41.2) 5 (19.2) 23 (30.3)
Patients were divided into three groups according to the results of oral glucose tolerance test: group 1 (NGT), group 2 (newly diagnosed IGR), and group 3 (newly diag-
nosed  DM). Patients were divided into two  subgroups according to the results of coronary angiography, CAD and non-CAD group. Compared CAD with non-CAD in NGT
patients, *p < 0.05, **p < 0.01; compared CAD with non-CAD in IGR patients, †p < 0.05, ††p < 0.01; compared CAD with non-CAD in DM patients, ‡p < 0.05, ‡‡p < 0.01. The
unit  of plasma glucose in Matsuda index is mg/dl. The unit of plasma glucose in other index is mmol/l. Smoker (“yes” or “no”, yes smoker deﬁned as having smoked
more  than three cigarettes a day for at least one year). NGT, normal glucose tolerance; IGR, impaired glucose regulation; DM,  diabetes mellitus; CAD, coronary artery
disease;  BMI, body mass index; Waist, waist circumstance; SBP, systolic blood pressure; DBP, diastolic blood pressure; Glu0, fasting plasma glucose; Ins0, fasting insulin;
HOMAIR, homeostasis model assessment of insulin resistance; C-peptide0, fasting C-peptide; AUC, area under the curve; Ins, insulin; Glu, glucose; AUC-Ins/Glu, AUC-Ins/AUC-
Glu  = (0.5 × Ins0 + Ins30 + Ins60 + Ins120 + 0.5 × Ins180)/(0.5 × Glu0 + Glu30 + Glu60 + Glu120 + 0.5 × Glu180); HbA1c, hemoglobin A1c; TC, total cholesterol; TG, triglycerides;
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iDL-C,  high density lipoprotein cholesterol; LDL-C, low density lipoprotein choleste
rotein; ACE-I angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor
OR 2.025 95%CI 1.197–3.426) were independent risk factors for
he presence of CAD in NGT patients (Table 2, model 1).
After adjustment for gender, age, BMI, DBP, fasting glucose,
bA1c, TC, TG, and HDL-C, using a second model, multivariate
ogistic regression analysis showed that smoking (OR 2.536 95%CI
.043–6.162), waist circumference (OR 1.050 95%CI 1.007–1.096),
BP (OR 1.033 95%CI 1.008–1.058), LDL-C (OR 2.170 95%CI
.263–3.730), and Matsuda index (OR 0.848 95%CI 0.758–0.949)
ere independent risk factors for the presence of CAD in NGT
atients (Table 2, model 2).
After adjustment for gender, BMI, SBP, DBP, fasting glucose,
bA1c, TC, TG, HDL-C, and LDL-C, multivariate logistic regres-
ion analysis showed that age (OR 1.065 95%CI 1.003–1.131),
moking (OR 4.831 95%CI 1.296–18.009), waist circumference (OR
.101 95%CI 1.025–1.182), and Matsuda index (OR 0.793 95%CI
.652–0.963) were independent risk factors of the presence of CAD
n newly diagnosed IGR patients (Table 3).
After adjustment for gender, smoking, BMI, waist circumfer-
nce, DBP, HbA1c, TC, and TG, multivariate logistic regression
nalysis showed that age (OR 1.097 95%CI 1.026–1.173), SBP
OR 1.069 95%CI 1.022–1.119), fasting glucose (OR 1.667 95%CI
.005–2.767), HDL-C (OR 0.051 95%CI 0.006–0.460), LDL-C (OR
.407 95%CI 1.834–10.588), and Matsuda index (OR 0.447 95%CI
.269–0.742) were independent risk factors of the presence of CAD
n newly diagnosed DM patients (Table 3).cr, serum creatinine; BUN, blood urea nitrogen; hs-CRP, high-sensitivity C-reactive
er.
Discussion
OGTT is widely used in clinical practice. It is the gold stan-
dard for evaluating the status of glucose metabolism, and it is also
the common method to assess insulin secretion and insulin sensi-
tivity, especially in large clinical and epidemiological studies. We
recruited 316 patients without history of type 2 DM.  According to
the results of OGTT, they were divided into three groups (NGT, IGR,
and DM). All patients with known or suspected CAD underwent
coronary angiography and they were divided into two  subgroups
(CAD and non-CAD). We  selected the insulin sensitivity indices
(HOMAIR and Matsuda index) to assess the insulin resistance of
patients. As shown in Table 1, univariate analysis revealed that
HOMAIR and Matsuda index were signiﬁcantly different between
CAD group and non-CAD group in all patients. As shown in Table 2,
multivariate analysis revealed that HOMAIR and Matsuda index
were independent risk factors for the presence of CAD in NGT
patients. As shown in Table 3, multivariate analysis revealed that
Matsuda index was  an independent risk factor for the presence of
CAD in newly diagnosed IGR and DM patients. However, HOMAIR
was statistically increased in the CAD group when compared to the
non-CAD group in newly diagnosed IGR and DM patients, but mul-
tivariate analysis indicated that HOMAIR was  not an independent
risk factor for the presence of CAD in newly diagnosed IGR  and DM
patients. The inconsistent results may  be because of the limitations
370 H. Wang et al. / Journal of Cardiology 60 (2012) 367–371
Fig. 1. Comparison of the levels of plasma glucose, insulin and C-peptide of the
divided groups. Comparison of the levels of plasma glucose, insulin, and C-peptide
was  according to OGTT in newly diagnosed NGT (triangles), IGR (circles), and
DM  (cubes) groups. Solid lines indicated CAD group and dotted lines indicated
non-CAD group. Values of plasma glucose, insulin, and C-reactive peptide are
the mean. Compared CAD with non-CAD in NGT patients, *p < 0.05, **p < 0.01;
compared CAD with non-CAD in IGR patients, †p < 0.05, ††p < 0.01; compared CAD
with non-CAD in DM patients, ‡p < 0.05, ‡‡p < 0.01. Comparing results between CAD
and non-CAD group were AUC-Glu (p = 0.007), AUC-Ins (p = 0.121), and AUC-Cp
(p  = 0.223) in NGT patients; comparing results between CAD and non-CAD group
were AUC-Glu (p = 0.163), AUC-Ins (p = 0.061), and AUC-Cp (p = 0.452) in newly
diagnosed IGR patients; comparing results between CAD and non-CAD group were
AUC-Glu (p = 0.438), AUC-Ins (p = 0.073), and AUC-Cp (p = 0.054) in newly diagnosed
DM patients. AUC-Glu = (0.5 × Glu0 + Glu30 + Glu60 + Glu120 + 0.5 × Glu180),
AUC-Ins = (0.5 × Ins0 + Ins30 + Ins60 + Ins120 + 0.5 × Ins180), AUC-
Cp  = (0.5 × Cp0 + Cp30 + Cp60 + Cp120 + 0.5 × Cp180). NGT, normal glucose
tolerance; CAD, coronary artery disease; IGR, impaired glucose regulation;
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Table 2
Logistic regression analysis of risk factors with the presence of CAD in NGT patients.
OR p-Value 95%CI
Model 1
Smoker 2.537 0.037 1.056–6.093
Waist 1.053 0.015 1.010–1.098
SBP 1.033 0.009 1.008–1.058
HOMAIR 2.221 0.015 1.166–4.231
LDL-C 2.025 0.009 1.197–3.426
Model 2
Smoker 2.536 0.040 1.043–6.162
Waist 1.050 0.023 1.007–1.096
SBP 1.033 0.010 1.008–1.058
LDL-C 2.170 0.005 1.263–3.730
Matsuda index 0.848 0.004 0.758–0.949
HOMAIR and Matsuda index had a Spearman correlation coefﬁcient of −0.925,
p  < 0.001 in NGT patients. It indicated a signiﬁcant correlation between the two vari-
ations. HOMAIR and Matsuda index cannot enter the regression model at the same
time because of collinearity. So we arrayed two separate multivariate regression
models (models 1 and 2). HOMAIR and other classic CAD risk factors were entered
into model 1. Matsuda index and other classic CAD risk factors were entered into
model 2. The other classic CAD risk factors included gender, age, smoking, BMI,
waist circumference, SBP, DBP, fasting glucose, HbA1c, TC, TG, HDL-C, and LDL-C. As
shown, multivariate logistic regression analysis indicated that HOMAIR and Matsuda
index were independent risk factors of the presence of CAD in NGT patients (CAD
was deﬁned as ≥50% of luminal stenosis in at least one major coronary vessel). CAD,
coronary artery disease; NGT, normal glucose tolerance; OR,  odds ratio; CI, conﬁ-
dence interval; Waist, waist circumstance; SBP, systolic blood pressure; HOMAIR,
homeostasis model assessment of insulin resistance; LDL-C, low density lipopro-
tein  cholesterol; smoker (“yes” or “no”, yes smoker deﬁned as having smoked more
than  three cigarettes a day for at least one year); BMI, body mass index; DBP, dias-
the pancreatic  cell to secrete more insulin (hyperinsulinemia)
to compensate for the inadequacy of insulin function and con-
straining the elevation of glucose. In the early stage of insulin
Table 3
Logistic regression analysis of risk factors with the presence of CAD in newly diag-
nosed IGR and DM patients.
OR p-Value 95%CI
Newly diagnosed IGR patients
Age 1.065 0.041 1.003–1.131
Smoker 4.831 0.019 1.296–18.009
Waist 1.101 0.008 1.025–1.182
Matsuda index 0.793 0.019 0.652–0.963
Newly diagnosed DM patients
Age 1.097 0.007 1.026–1.173
SBP 1.069 0.004 1.022–1.119
Glu0 1.667 0.048 1.005–2.767
HDL-C 0.051 0.008 0.006–0.460
LDL-C 4.407 0.001 1.834–10.588
Matsuda index 0.447 0.002 0.269–0.742
HOMAIR, Matsuda index and other classic CAD risk factors were as independent
variables of logistic regression analysis. The other classic CAD risk factors included
gender, age, smoker, BMI, waist circumference, SBP, DBP, fasting glucose, HbA1c,
TC,  TG, HDL-C and LDL-C. Multivariate logistic regression analysis indicated that
Matsuda index was  an independent risk factor for the presence of CAD in newly diag-
nosed IGR and DM patients (CAD was deﬁned as ≥50% of luminal stenosis in at least
one major coronary vessel). CAD, coronary artery disease, IGR, impaired glucose reg-
ulation; DM,  diabetes mellitus; OR, odds ratio; CI, conﬁdence interval; smoker (“yes”
or  “no”, yes smoker deﬁned as having smoked more than three cigarettes a day for at
least one year); waist, waist circumstance; SBP, systolic blood pressure; Glu0, fast-M,  diabetes mellitus; OGTT, oral glucose tolerance test; AUC, area under the
urve; Glu, glucose; Ins, insulin; Cp, C-peptide.
f HOMAIR. Some data suggest the accuracy of HOMAIR is lim-
ted by hyperglycemia [11]. The other limitation of HOMAIR is the
odel assumption that insulin sensitivity in the liver and periph-
ral tissues are equivalent, whereas it is known that they can differ
onsiderably in the same individual [11]. Many studies provided
vidence that insulin resistance was associated with accelerated
therosclerosis. Insulin resistance is directly related to endothelial
ysfunction [12] and associated with accelerated atherosclerosis intolic blood pressure; HbA1c, hemoglobin A1c; TC, total cholesterol; TG, triglyceride;
HDL-C, high density lipoprotein cholesterol.
the absence of overt DM [13,3,14]. The patients with IGR and DM
in our study were newly diagnosed, which is different from other
studies. However, we  came to a similar conclusion to other studies
[15,16].
The decrease in insulin sensitivity (insulin resistance) forceding  plasma glucose; HDL-C, high density lipoprotein cholesterol; LDL-C, low density
lipoprotein cholesterol; HOMAIR, homeostasis model assessment of insulin resis-
tance; BMI, body mass index; DBP, diastolic blood pressure; HbA1c, hemoglobin
A1c; TC, total cholesterol; TG, triglyceride.
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data from the Verona Diabetes Complications Study. Diabetes Care 2002;25:
1135–41.
[16] Hanley AJ, Williams K, Stern MP,  Haffner SM.  Homeostasis model assessmentH. Wang et al. / Journal of
esistance (compensatory phase), the body still can maintain the
lucose at normal level throughout compensatory insulin increase.
GR and DM develop when the  cells are unable to secrete more
nsulin to compensate for insulin resistance. As shown in Fig. 1,
nsulin levels after an oral glucose load increased signiﬁcantly
rom NGT via IGR to DM,  especially in the period of 60–180 min.
he present study adopted HOMA-, insulinogenic index, AUC-
ns/Glu to assess insulin secretion both in basic state and after an
ral glucose load respectively. As shown in Table 1, these indices,
emonstrated that the basic, early phase, and late-phase insulin
ecretion, were not signiﬁcantly different between CAD and non-
AD groups with different glucose metabolic status. Multivariate
ogsitic regression analysis showed that HOMA-, insulinogenic
ndex and AUC-Ins/Glu were not independent risk factors for the
resence of CAD (data not shown). Furthermore, there were no sig-
iﬁcant differences in the levels of AUC-insulin and AUC-C-peptide
etween the non-CAD group and the CAD group among the three
roups. Fujiwara et al. [5] found that the elevation of plasma insulin
oncentrations in both the sum and the early phase to an oral glu-
ose load were signiﬁcantly higher in CAD than in the normal group
ith different glucose metabolic status. It came to a different con-
lusion from our study. The reasons for this may  be as following:
rst, in Fujiwara’s study CAD was considered to be present if ≥one
esions narrowed the lumen of any of the 15 arterial segments by
75%. Second, the criteria for participants were different, such as
he patients in the IGR and DM groups in our study were newly
iagnosed, and the patients Fujiwara’s study were normolipidemic
ubjects. The fact of the inconsistent results needs to be further
emonstrated.
In this study the indices of insulin sensitivity and secretion
ere obtained from OGTT, not the euglycemic-hyperinsulinemic
nd the hyperglycemic clamp technique. It is the main limitation
f our study. The relatively small study population of each group
s another important limitation. Our study was cross-sectional, not
andomized, not prospective, just evaluating the CAD by coronary
ngiography without the use of intravascular ultrasound.
In conclusion, insulin resistance is closely related to the pres-
nce of CAD in newly diagnosed patients with different glucose
etabolic status. Effective intervention to treat insulin resistance is
ecessary during the prophylaxis and treatment of CAD. The insulin
ecretion may  not be closely related to the presence of CAD in NGT
nd newly diagnosed IGR and DM patients. The problem remains
o be further solved by prospective and large sample studies.
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